Health minister Zweli Mkhize hosted a public briefing on Wednesday morning to address the Oxford-AstraZeneca vaccine’s lack of effectiveness against the 501Y.V2  Covid-19 variant. The minister said the outcomes of the efficacy studies “shocked everyone”. He said the department will continue with the planned phase 1 vaccination rollout using the Johnson & Johnson (J&J) vaccine instead of the Oxford-AstraZeneca vaccine. “The J&J vaccine has proved to be effective against the 501Y.V2 variant and the necessary approval processes for use in SA are in progress,” said Mkhize.He said the nationwide phase 1 vaccine rollout is expected to start  next week, with the exact date to be announced by  cabinet. Subscribe to MultimediaLIVE here. TimesLIVE